Related Experiment Video
Updated: May 11, 2026

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent
Aarti D Rohira1, Chun-Yuan Chen, Justin R Allen
1Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California and the Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA.
Abstract:
RNA polymerase (pol) III transcribes genes that determine biosynthetic capacity. Induction of these genes is required for oncogenic transformation. The transcriptional repressor, Maf1, plays a central role in the repression of these and other genes that promote oncogenesis. Our studies identify an important new role for SUMOylation in repressing RNA pol III-dependent transcription. We show that a key mechanism by which this occurs is through small ubiquitin-like modifier (SUMO) modification of Maf1 by both SUMO1 and SUMO2. Mutation of each lysine residue revealed that Lys-35 is the major SUMOylation site on Maf1 and that the deSUMOylase, SENP1, is responsible for controlling Maf1K35 SUMOylation. SUMOylation of Maf1 is unaffected by rapamycin inhibition of mammalian target of rapamycin (mTOR) and mTOR-dependent Maf1 phosphorylation. By preventing SUMOylation at Lys-35, Maf1 is impaired in its ability to both repress transcription and suppress colony growth. Although SUMOylation does not alter Maf1 subcellular localization, Maf1K35R is defective in its ability to associate with RNA pol III. This impairs Maf1 recruitment to tRNA gene promoters and its ability to facilitate the dissociation of RNA pol III from these promoters. These studies identify a novel role for SUMOylation in controlling Maf1 and RNA pol III-mediated transcription. Given the emerging roles of SENP1, Maf1, and RNA pol III transcription in oncogenesis, our studies support the idea that deSUMOylation of Maf1 and induction of its gene targets play a critical role in cancer development.
Insights
SUMOylation of Maf1, a transcriptional repressor, is crucial for controlling RNA polymerase III transcription. This modification, regulated by SENP1, impacts gene expression and cell growth, offering new insights into oncogenesis.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- RNA polymerase III (pol III) transcribes genes vital for cell biosynthesis.
- Oncogenic transformation involves the induction of these genes.
- The transcriptional repressor Maf1 is key in repressing oncogenesis-promoting genes.
Purpose of the Study:
- To investigate the role of SUMOylation in repressing RNA pol III-dependent transcription.
- To elucidate the mechanism by which SUMOylation affects Maf1 function.
- To explore the implications of Maf1 SUMOylation in oncogenesis.
Main Methods:
- Investigated small ubiquitin-like modifier (SUMO) modification of Maf1 by SUMO1 and SUMO2.
- Identified Lys-35 as the major SUMOylation site on Maf1.
- Assessed the role of the deSUMOylase SENP1 in controlling Maf1 SUMOylation.
- Examined the effect of SUMOylation on Maf1's interaction with RNA pol III and its recruitment to promoters.
Main Results:
- SUMOylation of Maf1 by SUMO1 and SUMO2 was identified as a key mechanism for repressing RNA pol III transcription.
- Lys-35 was confirmed as the primary SUMOylation site, regulated by SENP1.
- Maf1 SUMOylation is independent of mTOR signaling.
- Impaired SUMOylation at Lys-35 hinders Maf1's transcriptional repression and colony growth suppression.
- SUMOylation does not affect Maf1 localization but impairs its association with RNA pol III, affecting promoter recruitment and dissociation.
Conclusions:
- SUMOylation of Maf1 is a novel regulatory mechanism controlling RNA pol III transcription.
- SENP1-mediated deSUMOylation of Maf1 and subsequent gene target induction play a critical role in cancer development.
- Targeting Maf1 SUMOylation presents a potential therapeutic strategy for cancers driven by aberrant RNA pol III activity.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins

